Viridian Therapeutics, Inc./DE
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-54.6M | $-54.9M | $338.0K | $14.5M |
| FY2022 | $-93.8M | $-94.6M | $797.0K | $19.8M |
| FY2023 | $-184.2M | $-185.1M | $898.0K | $67.2M |
| FY2024 | $-232.3M | $-232.8M | $511.0K | $42.2M |
| FY2025 | $-276.4M | $-276.9M | $495.0K | $44.3M |